Symbol: |
EPM2A
|
Description: |
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) [Source:HGNC Symbol;Acc:3413]
|
Location: |
Chr6:145822719-146057160[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:180
Gene |
Compound |
Gen_sig |
Exp_pattern |
EPM2A |
NSC 658420 |
0.017 |
Down |
EPM2A |
1,3-dimethyl-2,4-dioxo(1H,3H)pyrimido dimethyltetrathiafulvalene |
0.001 |
Up |
EPM2A |
NSC 660331 |
0.047 |
Down |
EPM2A |
2-bromo-8-methoxy-6-methyl-1,4-naphthoquinone |
0.017 |
Down |
EPM2A |
NSC 662119 |
0.031 |
Down |
EPM2A |
NSC 664160 |
0.038 |
Up |
EPM2A |
NSC 665277 |
0.012 |
Down |
EPM2A |
NSC 665759 |
0.036 |
Down |
EPM2A |
NSC 669308 |
0.02 |
Up |
EPM2A |
NSC 669608 |
0.025 |
Up |
EPM2A |
trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid |
0.013 |
Down |
EPM2A |
Ethanamine, N,N-dimethyl-2-[4-(1,1-dimethylethyl)- 1-[(4-methylphenyl)methyl]cyclohexyloxy]-, (trans)-, (E)-2-butenedioate (fumaric acid) (1:1) |
0.036 |
Down |
EPM2A |
NSC 670285 |
0.008 |
Down |
EPM2A |
NSC 670296 |
0.043 |
Down |
EPM2A |
NSC 670316 |
0.046 |
Down |
Expression pattern: Sensitivity / Resistance
Total:12 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:42
Total:3 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:10
Total:1 Current:1
[First] [Prev] [Next] [Last]
|